Lv3
320 积分 2025-05-27 加入
The evolving landscape of obesity pharmacotherapy
2个月前
已完结
Mitigation of pre-existing immunogenicity in ADA method development
4个月前
已完结
Streamlined neutralizing antibody assay development: overcoming serum interference, utilization of DOE and automation
4个月前
已完结
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
9个月前
已完结